Two Sigma Investments, LP Geo Vax Labs, Inc. Transaction History

Two Sigma Investments, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.55 - $17.1 $49,924 - $1.55 Million	-90,772 Reduced 78.45%	24,939 $15,000
Q3 2022 Nov 14, 2022	SELL	$0.4 - $58.5 $3,906 - $571,369	-9,767 Reduced 7.78%	115,711 $126,000
Q2 2022 Aug 15, 2022	BUY	$9.29 - $34.8 $911,859 - $3.42 Million	98,155 Added 359.24%	125,478 $104,000
Q1 2022 May 16, 2022	BUY	$17.25 - $58.95 $471,321 - $1.61 Million	27,323 New	27,323 $31,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.